Clinical Pharmacology for Pediatricians. II. Antisickling agents, with special reference to new vasoerythroactive drugs.
D000138:Acidosis / Q000188:drug therapy; D000755:Anemia, Sickle Cell / Q000150:complications / Q000188:drug therapy*; D000986:Antisickling Agents / Q000627:therapeutic use*; D001381:Azepines / Q000627:therapeutic use; D001847:Bone Diseases / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D004910:Erythrocyte Membrane / Q000187:drug effects; D005260:Female; D006451:Hemoglobin, Sickle / Q000378:metabolism; D006801:Humans; D000860:Hypoxia / Q000188:drug therapy; D007223:Infant; D007239:Infections / Q000209:etiology; D009461:Neurologic Manifestations; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D014652:Vascular Diseases / Q000188:drug therapy
D000986:Antisickling Agents; D001381:Azepines; D006451:Hemoglobin, Sickle; C006955:cetiedil